Rethinking diagnostics in the fight against antimicrobial resistance
Alejandra Sanchez and Ben Wicks explore why primary care needs timely, pragmatic insight, not lab-grade certainty, to enable better antibiotic decisions and stewardship.
Unlocking the potential of IP-free gene editing to gain commercial advantage
CC’s transdisciplinary development team has created a way to democratise gene editing. This IP-free gene editing method avoids the timescales and costs involved with commercially licensing current CRISPR/Cas9 editing techniques.
Engineering biology is driving the new bio-industrial revolution
Engineering biology, the fusion of biology and engineering principles, will be key to solving some of humanity’s most urgent challenges – from climate change and food security to healthcare and more
Quantum computing in 2025: from dream to deployment
Quantum computing has moved from theory and science fiction to become a strategy for business growth, with transformative rewards for those willing to engage with its complexities
Next generation autoinjectors: balancing Patient, Pharma, Payers and Planet
Our team use a reusable autoinjector case study to outline the product development approach needed to improve outcomes for patients, pharma, payers and the planet.
How digital twin innovation can accelerate healthcare product development
Deep tech consultants explore the challenges and rewards of implementing a digital twin prototype to accelerate healthcare product development